Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention

被引:97
|
作者
Tong, Xin [1 ]
Pelling, Jill C.
机构
[1] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA
关键词
Akt; mTOR; apigenin; cancer; CELL-CYCLE ARREST; CHEMOPREVENTIVE BIOFLAVONOID APIGENIN; CYCLOOXYGENASE-2; COX-2; EXPRESSION; SIGNAL-TRANSDUCTION PATHWAYS; GLUTATHIONE-S-TRANSFERASE; HUMAN PANCREATIC-CANCER; CYTOCHROME-C RELEASE; FLAVONOID APIGENIN; DIETARY FLAVONOIDS; TUMOR-CELLS;
D O I
10.2174/18715206113139990119
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural products are important sources of anti-cancer lead molecules, and high dietary consumption of fruits and vegetables is associated with a reduced risk of certain cancers. Many efforts have been devoted to identifying and developing plant-derived dietary constituents as chemopreventive agents. Among them, apigenin, a naturally occurring flavonoid found in a variety of fruits and leafy vegetables, has been shown to possess remarkable anti-oxidant, anti-inflammatory and anti-carcinogenic properties. This review summarizes the anti-cancer and chemopreventive effects of apigenin at cellular and molecular levels, its chemical structure and properties, with focus on mechanism related to apigenin's inhibition of the PI3K/Akt/mTOR signaling pathways.
引用
收藏
页码:971 / 978
页数:8
相关论文
共 50 条
  • [1] Targeting PI3K/Akt/mTOR signaling in cancer
    Porta, Camillo
    Paglino, Chiara
    Mosca, Alessandra
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [2] Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphoma
    Blachly, James S.
    Baiocchi, Robert A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (01) : 19 - 32
  • [3] Targeting PI3K/Akt/mTOR Pathway by Different Flavonoids: A Cancer Chemopreventive Approach
    Zughaibi, Torki A.
    Suhail, Mohd
    Tarique, Mohammad
    Tabrez, Shams
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [4] Targeting PI3K/mTOR signaling in cancer
    Arcaro, Alexandre
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [5] Targeting the PI3K/Akt/mTOR Pathway - Beyond Rapalogs
    Markman, Ben
    Dienstmann, Rodrigo
    Tabernero, Josep
    ONCOTARGET, 2010, 1 (07) : 530 - 543
  • [6] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [7] Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
    Li, Huayi
    Prever, Lorenzo
    Hirsch, Emilio
    Gulluni, Federico
    CANCERS, 2021, 13 (14)
  • [8] PI3K/AKT/mTOR Targeting in Colorectal Cancer Radiotherapy: A Systematic Review
    Mousavikia, Sn
    Darvish, L.
    Firouzjaei, Aa
    Toossi, M. T. Bahreyni
    Azimian, H.
    JOURNAL OF GASTROINTESTINAL CANCER, 2025, 56 (01)
  • [9] PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
    Alzahrani, Ali S.
    SEMINARS IN CANCER BIOLOGY, 2019, 59 : 125 - 132
  • [10] Targeting PI3K/AKT/mTOR network for treatment of leukemia
    Bertacchini, Jessika
    Heidari, Nazanin
    Mediani, Laura
    Capitani, Silvano
    Shahjahani, Mohammad
    Ahmadzadeh, Ahmad
    Saki, Najmaldin
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (12) : 2337 - 2347